Charted
Wednesday, Nov. 18, 2026The business of health, by the numbers
Live trackersDeal tracker $7.07B raisedFDA clearances 293 510(k)s in OctoberForm D raises $839M in 30 daysNew trials 266 Phase 2/3 in 30 days

Neocis wins FDA clearance to use its Yomi S dental robot for pterygoid implants

FDA cleared the expanded use Oct. 13 under K261321, and the Miami company announced it Oct. 29. The filing relied on bench and human factors testing and added no new device capabilities for that use, according to FDA's summary.

Charted Staff2 min read
From FDA's 510(k) database and decision summary, openFDA, and a company announcement published Oct. 29, 2026
The Yomi S robotic system with its display screen.
The Yomi S robotic system with its display screen.Courtesy of Neocis

Neocis can now market its Yomi S dental robot and YomiPlan planning software for pterygoid implants, which anchor in bone at the back of the upper jaw. The Food and Drug Administration cleared the expanded use Oct. 13, and the Miami company announced it Oct. 29.

Why it matters: The clearance adds a procedure to the list Yomi S can be sold for, one Neocis says its customers had asked it to support. According to FDA's summary, the company got there with performance testing and labeling updates for an existing device rather than new device capabilities, less than a year after the predicate version of Yomi S was cleared.

The clearance, K261321, was reviewed by FDA's dental panel as a traditional 510(k). FDA received the submission April 22 and decided it 174 days later. The device is classified as a dental navigation system under 21 CFR 872.4120, product code QRY.

The predicate was an earlier version of Yomi S cleared Oct. 28, 2025, under K252376, according to the 510(k) summary and openFDA records. The summary says pterygoid use brought no new device capabilities or changes. It separately notes minor modifications, unrelated to pterygoid placement, made since that earlier clearance.

Bench tests on synthetic bone models of the rear upper jaw and pterygoid region measured robotic and overall system accuracy under demanding conditions such as maximum drill length and implant angle, and FDA's summary says the system met its accuracy acceptance criteria. In human factors testing, dental surgeons and general dentists planned and performed simulated procedures using only the instruction manuals and software prompts.

The updated labeling adds instructions and warnings on assessing nearby blood vessels and nerves, evaluating bone density and making sure CT imaging covers the pterygoid region, according to the summary.

Neocis described pterygoid implants as 15 to 24 millimeters long and placed at angles of 17 to 45 degrees. The company said they can make a sinus lift unnecessary and make full-arch treatment possible for patients with significant bone loss in the upper jaw.

"Pterygoid placement is one of the procedures where our customers have been asking for support," Alon Mozes, Neocis's co-founder and chief executive, said in the announcement.

Yomi S already holds clearances for single-tooth, multiple-tooth, full-arch and dual-arch implant procedures, plus guided alveoplasty, a bone-reduction procedure, the company said. Neocis said Yomi has assisted in placing more than 125,000 implants.

The company is venture-backed. It lists NVIDIA's NVentures, Intuitive Surgical's Intuitive Ventures, DFJ Growth, Mithril Capital Management, Norwest Venture Partners and Fred Moll among its backers.

Neocis described the pterygoid clearance as part of a continuing expansion of indications on a single robotic platform, without saying which procedures it plans to pursue next.

Stories bylined Charted Staff are produced by the Charted newsroom from public documents: company announcements, SEC filings, FDA databases and federal rules. Each one lists the documents it was drawn from. Drafted with automated tools from the sources listed with this story and checked against them before publishing. How we report.

More Devices & FDA

More
Newsletter

Charted Daily

The day's deals, FDA decisions and policy moves, by the numbers. Free. Sign up now to get the first edition.

No spam. Unsubscribe any time.